4.7 Article

Side effects of low-dose tamoxifen: results from a six-armed randomised controlled trial in healthy women

Journal

BRITISH JOURNAL OF CANCER
Volume 129, Issue 1, Pages 61-71

Publisher

SPRINGERNATURE
DOI: 10.1038/s41416-023-02293-z

Keywords

-

Categories

Ask authors/readers for more resources

Based on questionnaire data from a randomized controlled trial, low-dose tamoxifen was associated with fewer side effects compared to standard dose tamoxifen in healthy women. These side effects mainly included hot flashes, night sweats, cold sweats, vaginal discharge, and muscle cramps. The dose-dependent difference was primarily influenced by menopausal status.
BackgroundAdherence to adjuvant tamoxifen therapy is suboptimal, and acceptance of tamoxifen for primary prevention is poor. Published results indicate effect of low-dose tamoxifen therapy. Using questionnaire data from a randomised controlled trial, we describe side effects of standard and low-dose tamoxifen in healthy women.MethodsIn the KARISMA trial, 1440 healthy women were randomised to 6 months of daily intake of 20, 10, 5, 2.5, 1 mg of tamoxifen or placebo. Participants completed a 48-item, five-graded Likert score symptom questionnaire at baseline and follow-up. Linear regression models were used to identify significant changes in severity levels across doses and by menopausal status.ResultsOut of 48 predefined symptoms, five were associated with tamoxifen exposure (hot flashes, night sweats, cold sweats, vaginal discharge and muscle cramps). When comparing these side effects in premenopausal women randomised to low doses (2.5, 5 mg) versus high doses (10, 20 mg), the mean change was 34% lower in the low-dose group. No dose-dependent difference was seen in postmenopausal women.ConclusionsSymptoms related to tamoxifen therapy are influenced by menopausal status. Low-dose tamoxifen, in contrast to high-dose, was associated with less pronounced side effects, a finding restricted to premenopausal women. Our findings give new insights which may influence future dosing strategies of tamoxifen in both the adjuvant and preventive settings.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available